Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer

Published:2020-09-01 Issue:9 Volume:6 Page:1460
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Hadar Tal¹,Mor Pnina²³,Amit Gefen⁴,Lieberman Sari³,Gekhtman David⁵,Rabinovitch Rachel⁶,Levy-Lahad Ephrat³⁴

Affiliation:

1. Breast Surgery Unit, Department of Surgery, Shaare Zedek Medical Center, Jerusalem, Israel

2. Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel

3. Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel

4. Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

5. Breast Imaging Unit, Department of Imaging, Shaare Zedek Medical Center, Jerusalem, Israel

6. Departments of Radiation Oncology and Medicine, University of Colorado, Anschutz Medical Campus, Aurora

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2768011/jamaoncology_hadar_2020_ld_200020_1599154625.97284.pdf

Reference6 articles.

1. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.;Gabai-Kapara;Proc Natl Acad Sci U S A,2014

2. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.;Marchetti;BMC Womens Health,2014

3. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.;Heemskerk-Gerritsen;Breast Cancer Res Treat,2019

4. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.;Metcalfe;Br J Cancer,2019

5. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020.;Daly;J Natl Compr Canc Netw,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review;Journal of Modern Oncology;2024-03-05

2. The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy;Breast Cancer Research and Treatment;2024-02-12

3. Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation;Cold Spring Harbor Perspectives in Medicine;2023-12-27

4. The Impact of Germline BRCA Mutations in Locally Advanced, Triple Negative Breast Cancer Treated with Platinum Based Neoadjuvant Chemotherapy;2023-12-26

5. Breast cancer screening in germline mutation carriers. A literature review;Tumors of female reproductive system;2023-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3